Biểu đồ giá cổ phiếu MLTX
MLTX Cổ tức
MoonLake Immunotherapeutics
$19.9
-0.45%
$-0.08
Khi đóng cửa: Jun 26, 16:00:00 GMT-4
$20.24
1.7%
$0.33
Phiên trước giờ: Jun 29, 06:03:18 GMT-4
Quay lại
MoonLake Immunotherapeutics (MLTX) Cổ tức
Thống kê chính
Giá đóng cửa trước
$19.99
Giá mở cửa
$20.01
Phạm vi ngày
$19.78 - $20.34
Phạm vi 52 tuần
$5.95 - $62.75
Khối lượng
1.6M
Khối lượng trung bình
1.0M
Tỷ suất cổ tức
--
EPS (TTM)
-3.87
Vốn hóa thị trường
$1.4B
MLTX là gì?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
